Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China · Delayed Price · Currency is CNY
70.26
+0.89 (1.28%)
May 8, 2026, 3:04 PM CST

SHE:300573 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,6002,4531,9241,4401,2271,024
Other Revenue
19.9219.9219.4927.8623.23.6
2,6202,4731,9431,4681,2501,028
Revenue Growth (YoY)
23.03%27.24%32.42%17.42%21.59%49.26%
Cost of Revenue
494.19477.94424.53340.36270.08229.01
Gross Profit
2,1261,9951,5191,127979.78798.91
Selling, General & Admin
974.5938.52875.78689.8595.39456.54
Research & Development
263.31225.91220.66167.3145.6188.45
Other Operating Expenses
32.4318.9210.687.166.6613.8
Operating Expenses
1,2711,1841,110867.29748.58558.6
Operating Income
854.39810.48408.42259.93231.2240.31
Interest Expense
-3.42-4.44-5.71-1.44-0.94-5.99
Interest & Investment Income
1.942.255.667.919.933.98
Currency Exchange Gain (Loss)
-1.67-1.67-0.110.2-0.09-0.13
Other Non Operating Income (Expenses)
0.09-1.49-2.11-1.15-19.31-1.05
EBT Excluding Unusual Items
851.34805.14406.15265.45220.79237.12
Gain (Loss) on Sale of Investments
---0.02---
Gain (Loss) on Sale of Assets
-0.020.05-0.98-0.040.425.16
Asset Writedown
2.67-3.7-14.05--0-0
Other Unusual Items
-1.13-1.223.94-0.4212.511.26
Pretax Income
852.86800.28395.03264.99233.72243.54
Income Tax Expense
96.49104.4256.9724.9622.0334.43
Earnings From Continuing Operations
756.37695.86338.06240.04211.68209.11
Minority Interest in Earnings
------14.41
Net Income
756.37695.86338.06240.04211.68194.7
Net Income to Common
756.37695.86338.06240.04211.68194.7
Net Income Growth
68.38%105.84%40.84%13.39%8.72%121.31%
Shares Outstanding (Basic)
245246245244241224
Shares Outstanding (Diluted)
245246245244241224
Shares Change (YoY)
-0.20%0.37%0.60%0.96%7.45%-0.30%
EPS (Basic)
3.082.831.380.990.880.87
EPS (Diluted)
3.082.831.380.990.880.87
EPS Growth
68.72%105.07%40.00%12.32%1.19%120.40%
Free Cash Flow
507.4482.86218.2755.61-12.96211.9
Free Cash Flow Per Share
2.071.960.890.23-0.050.94
Dividend Per Share
1.7001.7001.0711.8880.5470.237
Dividend Growth
58.67%58.67%-43.25%245.37%130.73%160.04%
Gross Margin
81.14%80.67%78.16%76.81%78.39%77.72%
Operating Margin
32.61%32.77%21.02%17.71%18.50%23.38%
Profit Margin
28.87%28.14%17.39%16.36%16.94%18.94%
Free Cash Flow Margin
19.37%19.53%11.23%3.79%-1.04%20.61%
EBITDA
957.19911.51502.42340.3297.23297.55
EBITDA Margin
36.53%36.86%25.85%23.19%23.78%28.95%
D&A For EBITDA
102.8101.049480.3866.0357.24
EBIT
854.39810.48408.42259.93231.2240.31
EBIT Margin
32.61%32.77%21.02%17.71%18.50%23.38%
Effective Tax Rate
11.31%13.05%14.42%9.42%9.43%14.14%
Revenue as Reported
2,6202,4731,9431,4681,2501,028
Advertising Expenses
---13.81135.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.